CDH4 and osteosarcoma: Similarly, CDH4 deficiency impacts the invasion of human osteosarcoma cells (Tang et al., 2018), and epithelial ovarian cancer (EOC) invasion is mediated by ITGAM (Lyu et al., 2020).